PortfoliosStock ScreensStocksStockXcel

iSpecimen Inc. Common Stock

ISPC | US

0.28

USD

0.06

26.96%

ISPC | US
Loading StockChartView...

About iSpecimen Inc. Common Stock

Sector

Healthcare

Industry

Diagnostics & Research

Earnings date

30/06/2024

As of date

13/03/2026

Close

0.28

Open

0.43

High

0.44

Low

0.28

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids tissues and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals labs biobanks blood centers and other healthcare organizations. The company develops and operates iSpecimen Marketplace a proprietary online marketplace platform that connects medical researchers who need access to subjects samples and data with hospitals laboratories and other organizations who have access to them. It serves biopharmaceutical companies in vitro diagnostic companies and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington Massachusetts.

View Less

ISPC | US

Risk
140.3
Sharpe
-0.40
Luna's Score
57/100
Recommendation
Hold

Luna says (ISPC | US)

What's Working

Strength based on increasing price with high volume

High Current Volume and Positive 1-Day Return

Low Debt to Equity (< 0.25)

Low Debt to Asset (< 0.2)

Value Stock (Price to Book < 3)

Strong Revenue Growth (> 10%)

What's not Working

High Short-term Volatility

High 6-Month Volatility (>65%)

Microcap (<300M USD)

High Market Beta (> 0.8)

Weak Operating Margin (< 10%)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

Loading RiskMeterView...

10 days

169.3%

1 month

140.3%

3 months

132.7%

6 months

139.2%

Returns

Loading ReturnMeterView...

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

0.44

Debt to equity

0.00

Debt to assets

0.00

Ent. to EBITDA

0.43

Ent. to rev.

0.05

PEG

-

Other Fundamentals

EBITDA

-10.03M

MarketCap

186.24K

MarketCap(USD)

186.24K

Div. yield

-

Op. margin

-76.18

Erngs. growth

-

Rev. growth

76.20

Ret. on equity

-98.03

Short ratio

0.25

Short perc.

11.03

Market Sentiment (SMA and Price signals)

Short-term: Bearish (SMA10D < SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Loading MovingAverageView...

Range10D

0.22

Range1M

0.22

Range3M

0.26

Volumes: Market Activity

Volume Averages

Loading VolumeAverageView...

Rel. volume

17.71

Price X volume

76.77M

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
bioAffinity Technologies Inc. WarrantBIAFWDiagnostics & Research0.3299036.10%n/a40.20%
STRRPSTRRPDiagnostics & Research10.0600.20%n/a26.85%
Prenetics Holding Company LimitedPRENWDiagnostics & Research0.02020n/a0.63%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
No data

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA0.4312.67Cheaper
Ent. to Revenue0.0544.00Cheaper
PE Ratio-40.09-
Price to Book0.4477.50Cheaper
Dividend Yield-1.18-
Std. Deviation (3M)132.7359.59Riskier
Debt to Equity0.00-14.36Expensive
Debt to Assets0.000.34Cheaper
Market Cap186.24K13.71BEmerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007